PRAX: Praxis Precision Medicines, Inc. Stock

by  •  • Comments Off on PRAX: Praxis Precision Medicines, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 1,227.11
Enterprise Value ($M) 1,058.47
Book Value ($M) 382.67
Book Value / Share 20.53
Price / Book 3.21
NCAV ($M) 380.60
NCAV / Share 20.42
Price / NCAV 3.22

Profitability (mra)
Return on Invested Capital (ROIC) -0.39
Return on Assets (ROA) -1.72
Return on Equity (ROE) -2.17

Liquidity (mrq)
Quick Ratio 13.59
Current Ratio 13.59

Balance Sheet (mrq) ($M)
Current Assets 414.19
Assets 416.26
Liabilities 33.59
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
11-14 13G/A Cormorant Asset Management, LP 4.67 37.37
11-14 13G Price T Rowe Associates Inc /md/ 6.30
11-14 13G/A Venrock Healthcare Capital Partners III, L.P. 5.00 10.06
11-14 13G/A Point72 Asset Management, L.P. 9.60 132.16
11-14 13G/A Verition Fund Management LLC 1.80 -55.29
11-14 13G/A Ra Capital Management, L.p. 4.30 -38.33
11-12 13G Capital Research Global Investors 5.60
11-12 13G/A Adage Capital Management, L.P. 4.81
11-12 13G/A Vanguard Group Inc 5.85 0.00
11-08 13G BlackRock, Inc. 7.30 0.00
09-23 13G Perceptive Advisors Llc 6.30
02-14 13G/A Eventide Asset Management, Llc 0.00
02-14 13G/A PFM Health Sciences, LP 0.50
02-14 13G/A Tri Locum Partners LP 2.80
02-13 13G/A Huang James 0.00 -100.00
02-13 13G/A Avidity Partners Management LP 0.00 -100.00
02-09 13G/A Blackstone Holdings I/II GP L.L.C. 0.80
02-07 13G/A Adage Capital Partners Gp, L.l.c. 8.40
02-06 13G/A Kingdon Capital Management, L.l.c. 2.90
02-05 13G/A Sphera Funds Management Ltd. 3.74 -96.25

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-11-06 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2024-08-13 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2024-05-13 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2024-03-05 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-K

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-01-15 50,235 321,767 15.61
2025-01-14 99,543 265,634 37.47
2025-01-13 42,260 254,249 16.62
2025-01-10 119,220 435,026 27.41

(click for more detail)

Similar Companies
PHVS – Pharvaris N.V. PLRX – Pliant Therapeutics, Inc.
PMVP – PMV Pharmaceuticals, Inc. PRLD – Prelude Therapeutics Incorporated
PRTA – Prothena Corporation plc


Financial data and stock pages provided by
Fintel.io